Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List
Natalia Elliot | November 19, 2024 | News story | | Chiesi, Corporate, best workplace
- Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best Workplaces™
- The accolade reflects Chiesi’s dedication to people’s well-being, continuous improvement, and creating a positive work environment
- Chiesi was also recently ranked in in the Best Workplaces in Europe™ 2024, Best Workplaces for Women™ in Greater China, and UK’s Best Workplaces in BioPharma™, among others
18 November 2024 – Manchester, UK – Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking 23rd on this year’s list.
The news marks the first time any European pharmaceutical company has achieved the accolade by the global authority on workplace culture. Headquartered in Parma, Italy, Chiesi has 31 offices worldwide and employs over 7,000 people. In the UK, the Chiesi headquarters is in Manchester, with a research and development facility also in Chippenham.
“Chiesi aims to be more than just a place of work, we want to be a community where growth, innovation and collaboration thrive,” said Kate Lenik, Senior Director, HR & Support Services, UK. “Our success is a collective achievement, built on the dedication and talent of every individual who is part of our team.”
Great Place To Work®, and Fortune’s annual list, selects 25 global organisations that participated in Great Place To Work’s employee survey process, with 7.4 million responses received, representing 20 million employees worldwide. To be considered for the list, companies must be identified as outstanding global employers with recognition on at least five Best Workplaces™ lists in Asia, Europe, Latin America, Africa, North America, or Australia during 2023 or early 2024.
“We are immensely proud to be the only European pharmaceutical company included in the World’s Best Workplaces™ rankings. Being part of such a selective global list of only 25 companies is a source of huge motivation for continuous improvement.” said Giuseppe Accogli, Chief Executive Officer, Chiesi Group. “This placement stems from our firm commitment to our people’s well-being, as it reflects their direct feedback and contribution in shaping Chiesi into a place where we all enjoy working. I believe this accolade will further increase our sense of pride and belonging to a company fully dedicated to serving patients around the world in everything we do.”
In addition to this latest recognition, in 2024 Chiesi was also ranked as one of the top 10 Best Workplaces in Europe™. In the UK specifically, Chiesi has been recognised for over a decade in employer and workplace culture awards being named as a UK Great Place to Work™, UK Best Workplace for Wellbeing, UK Best Workplace for Women and Menopause Friendly Employer.
About Chiesi Group: Chiesi is research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. Visit: www.chiesi.uk.com
Related Content
Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers
Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its …
NICE recommends treatment for rare genetic eye disorder
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending …
Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib
US-based clinical stage biopharma company Gossamer Bio and Italian research-focused biopharma group Chiesi Farmaceutici have …
